SOLID ORAL DOSAGE FORM OF TESTOSTERONE DERIVATIVE
The present invention relates to a pharmaceutical composition comprising a testosterone derivative having a log p of at least 5 and a vehicle, wherein the vehicle comprises a fat component in an amount sufficient to achieve lymphatic absorption in a mammal, wherein the fat component comprises a mono...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English French |
Published |
26.06.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a pharmaceutical composition comprising a testosterone derivative having a log p of at least 5 and a vehicle, wherein the vehicle comprises a fat component in an amount sufficient to achieve lymphatic absorption in a mammal, wherein the fat component comprises a mono- or triglyceride of long chain fatty acids
La présente invention concerne une composition pharmaceutique comprenant un dérivé de testostérone ayant un log P d'au moins 5 et un véhicule, le véhicule comprenant un composant lipidique dans une quantité suffisante pour obtenir l'absorption lymphatique chez un mammifère, le composant lipidique comprenant un mono- ou triglycéride d'acides gras à chaîne longue. |
---|---|
Bibliography: | Application Number: WO2013EP77300 |